A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples